Literature DB >> 23668403

Butyl methoxy dibenzoylmethane.

Jutta Kockler1, Sherryl Robertson, Michael Oelgemöller, Murray Davies, Bruce Bowden, Harry G Brittain, Beverley D Glass.   

Abstract

A comprehensive profile on Butyl methoxy dibenzoylmethane, one of the most commonly used ultraviolet (UV) filters in topical sunscreen products, is prepared. This UV filter, often referred to as Avobenzone, has its main absorbance in the UVA I region of the spectrum and is susceptible to photodegradation. The profile contains the following sections: general information, use and mechanism of action, method of preparation, physical characteristics, methods of analysis, stability, and toxicity. The physical characteristics section includes the melting range, differential scanning calorimetry, partition coefficient, ionization constant, solubility, and UV, infrared, nuclear magnetic resonance ((1)H NMR and (13)C NMR) and mass spectrometry and X-ray powder diffractometry. The method of analysis section in addition to compendial identification and purity and assay methods includes thin-layer gas and high-performance liquid chromatography. The photostability and photostabilization of Butyl methoxy dibenzoylmethane, in addition to its toxicity, are also documented.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23668403     DOI: 10.1016/B978-0-12-407691-4.00003-4

Source DB:  PubMed          Journal:  Profiles Drug Subst Excip Relat Methodol        ISSN: 1871-5125


  3 in total

1.  Sunscreens and their usefulness: have we made any progress in the last two decades?

Authors:  Nick Serpone
Journal:  Photochem Photobiol Sci       Date:  2021-02-18       Impact factor: 3.982

2.  [When sunscreens do not help: allergic contact dermatitis to UV filters].

Authors:  L Ludriksone; J Tittelbach; S Schliemann; S Goetze; P Elsner
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

3.  Development of a UV-Stabilized Topical Formulation of Nifedipine for the Treatment of Raynaud Phenomenon and Chilblains.

Authors:  Ellen K Wasan; Jinying Zhao; Joshua Poteet; Munawar A Mohammed; Jaweria Syeda; Kevin Soulsbury; Jacqueline Cawthray; Amanda Bunyamin; Chi Zhang; Brian M Fahlman; Ed S Krol
Journal:  Pharmaceutics       Date:  2019-11-09       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.